Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

        Public Health Focus

Expanded Access

                        
                Expanded Access | Information for Patients
          Expanded Access | Information for Physicians
          Expanded Access | Information for Industry
          Expanded Access | How to Submit a Request (Forms)
          Expanded Access | Keywords, Definitions, and Resources
          Expanded Access (Compassionate Use) Submission Data
          FDA's Expanded Access Contact Information Home
          News & Events
          Public Health Focus
          Expanded AccessPublic Health Focus Expanded Access
  	
        Share
    Post
    Linkedin

    Email
    PrintEspañol

Sometimes called “compassionate use”, expanded access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.

Doctor talking to patient

Expanded access may be appropriate when all the following apply:

Patient has a serious or immediately life-threatening disease or condition.
	There is no comparable or satisfactory alternative therapy to diagnose, monitor, or treat the disease or condition.
	Patient enrollment in a clinical trial is not possible.
	Potential patient benefit justifies the potential risks of treatment.
	Providing the investigational medical product will not interfere with investigational trials that could support a medical product’s development or marketing approval for the treatment indication.Investigational drugs, biologics or medical devices have not yet been approved or cleared by FDA and FDA has not found these products to be safe and effective for their specific use. Furthermore, the investigational medical product may, or may not, be effective in the treatment of the condition, and use of the product may cause unexpected serious side effects.

Information for Patients, Physicians and Industry

Patients

Learn about expanded access, including information about the expanded access process, what FDA considers, and what costs may be involved.

Physicians

Learn about expanded access, including information about the different types of expanded access, how to submit expanded access requests, and reporting requirements.

Industry

Learn about expanded access, including information about posting your expanded access policy, how to submit expanded access requests, and reporting requirements.

Forms

Learn about how to complete and submit forms needed for each type of expanded access request.

Key Contact Information

1. During Normal Business Hours (8 a.m. - 4:30 p.m. ET, weekdays)

For **specific questions** during normal business hours:

**Investigational drugs:** 301-796-3400 or druginfo@fda.hhs.gov [CDER's Division of Drug Information], or contact the appropriate review division, if known

	**Oncology drugs:** 240-402-0004 or ONCProjectFacilitate@fda.hhs.gov
	**Investigational medical devices:** 301-796-7100 or DICE@fda.hhs.gov [CDRH's Division of Industry and Consumer Education]
	**Investigational biologics:** 240-402-8020 or 800-835-4709 or industry.biologics@fda.hhs.gov [CBER's Office of Communication, Outreach and Development]For **general questions**, or if you are unsure of who to contact, contact the Patient Affairs Staff at 301-796-8460 or patientaffairs@fda.hhs.gov.

2. After 4:30 p.m. ET weekdays and all day on weekends

For **emergency requests** for all medical products (drugs, biologics, and medical devices) contact **FDA's Emergency Call Center** at 866-300-4374.


Report from the 2018 external assessment of the Expanded Access Program

                                                                                  Content current as of:
      12/21/2022Expanded Access                
                          

                        Information for Patients
          Information for Physicians
          Information for Industry
          How to Submit a Request (Forms)
          Keywords, Definitions, and Resources
          Submission Data
          Contact Information
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop